T 2266/11 (anamorelin/HELSINN) of 10.08.2015
- European Case Law Identifier
- ECLI:EP:BA:2015:T226611.20150810
- Date of decision
- 10 August 2015
- Case number
- T 2266/11
- Online on
- 14 August 2015
- Petition for review of
- -
- Application number
- 05766869.1
- IPC class
- C07D 401/06A61K 31/454A61P 5/06
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- CRYSTAL FORMS OF (3R)-1-(2-METHYLALANYL-D-TRYPTOPHYL)-3-(PHENYLMETHYL)-3-PIPERIDINECARBOXYLIC ACID 1,2,2-TRIMETHYLHYDRAZIDE
- Applicant name
- Helsinn Healthcare S.A.
- Opponent name
- -
- Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56
- Keywords
- Main Request:
Inventive step - (yes) -crystallisation of the base not obvious under the present circumstances - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first
instance with the order to grant a patent in the following version:
Description:
Pages 2-6, 8-22, 24-34 as originally filed
Pages 1, 35 and 35a, filed with the letter dated
21 May 2015;
Pages 7 and 23, filed with the letter dated
12 February 2015.
Claims:
Nos. 1-15 filed with the letter dated 21 May 2015.
Drawings:
Nos. 1/5-5/5 as originally filed.